Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation

Acta Dermato-Venereologica

Volumn 94, Issue 2, 2014, Pages 146-151

  Ala Houhala, Meri J ^a,b   Karppinen, Toni ^c   Vähävihu, Katja ^d   Kautiainen, Hannu ^e   Dombrowski, Yvonne ^f   Snellman, Erna ^c   Schauber, Jürgen ^f   Reunala, Timo ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d KANTA HÄME CENTRAL HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cathelicidin; CYP27A1; CYP27B1; Human defensin; Psoriasis; Ultraviolet B radiation; Vitamin D

Indexed keywords

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADMINISTRATION, ORAL; ADULT; BETA-DEFENSINS; BIOPSY; CHOLECALCIFEROL; CHOLESTANETRIOL 26-MONOOXYGENASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; ULTRAVIOLET THERAPY; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84894066837     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1685     Document Type: Article

References (34)

1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S.
2. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860-868.
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
4. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-1424.
5. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
6. Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117: 803-811.
7. Lehmann B, Meurer M. Vitamin D metabolism. Dermatol Ther 2010; 23: 2-12.
8. Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, Beltrami G, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012; 166: 505-510.
9. Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S, et al. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol 2012; 67: 931-938.
10. Romaní J, Caixàs A, Carrascosa JM, Ribera M, Rigla M, Luelmo J. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis. Br J Dermatol 2012; 166: 1237-1244.
11. Bandow GD, Koo JY. Narrow-band ultraviolet B radiation: a review of the current literature. Int J Dermatol 2004; 43: 555-561.
12. Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, et al. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Invest Dermatol 2011; 131: 1547-1558.
13. Lehmann B, Knuschke P, Meurer M. The UVB-induced synthesis of vitamin D3 and 1α,25-dihydroxyvitamin D3 (calcitriol) in organotypic cultures of keratinocytes: Effectiveness of the narrowband Philips TL-01 lamp (311nm). Steroid Biochem Molec Biol 2007; 103: 682-685.
14. Osmancevic A, Landin-Wilhelmsen K, Larkö O, Wennberg AM, Krogstad AL. Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 2009; 25: 119-123.
15. Vähävihu K, Ala-Houhala M, Peric M, Kautiainen H, Hasan T, Snellman E, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010; 163: 321-328.
16. Ryan C, Moran B, McKenna MJ, Murray BF, Brady J, Collins P, et al. The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland. Arch Dermatol 2010; 146: 836-842.
17. Lesiak A, Narbutt J, Pawlaczyk M, Sysa-Jedrzejowska A, Krzyścin J. Vitamin D serum level changes in psoriatic patients treated with narrowband ultraviolet B phototherapy are related to the season of the irradiation. Photodermatol Photoimmunol Photomed 2011; 27: 304-310.
18. Milliken SV, Wassall H, Lewis BJ, Logie J, Barker RN, Macdonald H, et al. Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function. J Allergy Clin Immunol 2012; 129: 1554-1561.
19. Peric M, Lehmann B, Vashina G, Dombrowski Y, Koglin S, Meurer M, et al. UV-B-triggered induction of vitamin D3 metabolism differentially affects antimicrobial peptide expression in keratinocytes. J Allergy Clin Immunol 2010; 125: 746-749.
20. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 261-266.
21. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40: 23-25.
22. Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Göss C, Anz D, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 2011; 3: 82ra38.
23. Ala-Houhala MJ, Vähävihu K, Hasan T, Kautiainen H, Ylianttila L, Viljakainen HT, et al. Comparison of narrow-band ultraviolet B exposures and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol 2012; 167: 160-164.
24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
25. Forsythe LK, Livingstone MB, Barnes MS, Horigan G, McSorley EM, Bonham MP, et al. Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br J Nutr 2012; 107: 126-134.
26. Bogh MK, Gullstrand J, Svensson Å, Ljunggren B, Dorkhan M. Narrowband ultraviolet B three times per week is more effective in treating vitamin D deficiency than 1600 IU oral vitamin D(3) per day: a randomized clinical trial. Br J Dermatol 2012; 167: 625-630.
27. Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol 2010; 130: 546-553.
28. Lehmann B. Role of the vitamin D3 pathway in healthy and diseased skin facts, contradictions and hypotheses. Clin Exp Dermatol 2009; 18: 97-108.
29. Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. A small suberythemal UVB dose every second week is sufficient to maintain summer vitamin D levels: a randomized controlled trial. Br J Dermatol 2012; 166: 430-433.
30. Felton S, Navid F, Schwarz A, Schwarz T, Gläser R, Rhodes LE. Ultraviolet radiation-induced upregulation of antimicrobial proteins in health and disease. Photochem Photobiol Sci 2012; 12: 29-36.
31. National Institute for Health and Welfare. [Changes in national recommendation for vitamin D supplementation 2011]. Available from: http://www.thl.fi/doc/fi/23892 [accessed 18 Apr 2013] (in Finnish).
32. Hearn RMR, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931-935.
33. Patel RV, Clark LN, Lebwohl M, Weinberg JM. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol 2009; 60: 1001-1017.
34. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 11: 709-715.